Ben-Chetrit Eldad, Yazici Hasan
Department of Medicine A, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel.
Department of Rheumatology, Academic Hospital, Istanbul, Turkey.
Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):108-112. Epub 2017 Jun 9.
Familial Mediterranean fever (FMF) is characterised by recurrent attacks of fever and serositis. It may affect the peritoneum, pleura, synovia and the skin. Usually the liver is intact in FMF. Recently, this concept was challenged by some groups which claimed that hepatitis is a feature of FMF and that non-alcoholic liver disease (NAFLD) and cryptogenic cirrhosis are more common among FMF patients. Scope of this paper is to critically review the relevant literature and to answer the question whether or not the liver is involved in FMF.
We used Medline, Embase, Scopus and Web of Science database for searching articles dealing with FMF and the liver since 1960. We also reviewed some manuscripts which were not identified by the above searching engines.
Some cases reported that hepatitis is a feature of FMF based upon transaminase elevations without liver biopsy. Due to this questionable diagnosis and the paucity of similar reports, it seems that hepatitis is not a feature of FMF. Cryptogenic cirrhosis is considered as the end stage of NAFLD. Since NAFLD is prevalent in 25% of the general population it is more plausible to relate the occurrence of cryptogenic cirrhosis in FMF patients to NAFLD rather than to FMF. M694V mutation carriage was relatively more frequent among FMF patients with cryptogenic cirrhosis or "hepatitis".
The literature review indicates that FMF and liver disease are not generally associated. However, carriage of M694V mutations may play a role in the pathogenesis of liver disease.
家族性地中海热(FMF)的特征为反复发热和浆膜炎发作。它可能影响腹膜、胸膜、滑膜和皮肤。通常在FMF中肝脏不受影响。最近,这一概念受到了一些研究团队的挑战,他们声称肝炎是FMF的一个特征,并且非酒精性肝病(NAFLD)和隐源性肝硬化在FMF患者中更为常见。本文的目的是批判性地回顾相关文献,并回答肝脏是否参与FMF这一问题。
我们使用Medline、Embase、Scopus和Web of Science数据库检索自1960年以来有关FMF和肝脏的文章。我们还查阅了一些上述搜索引擎未检索到的手稿。
一些病例报告称,基于转氨酶升高且未进行肝活检,肝炎是FMF的一个特征。由于这种可疑的诊断以及类似报告的匮乏,肝炎似乎并非FMF的特征。隐源性肝硬化被认为是NAFLD的终末期。由于NAFLD在普通人群中的患病率为25%,因此将FMF患者中隐源性肝硬化的发生与NAFLD而非FMF联系起来似乎更合理。在患有隐源性肝硬化或“肝炎”的FMF患者中,M694V突变携带者相对更为常见。
文献综述表明,FMF与肝脏疾病通常没有关联。然而,M694V突变的携带可能在肝脏疾病的发病机制中起作用。